The European Medicines Agency (EMA) on Monday (October 4th) approved the booster dose of the COVID-19 vaccine, Pfizer / BioNTech, for all people 18 years of age and older.
“The booster dose can be taken at least six months after the second dose,” the EMA said in a statement.
EMA drug experts have based their decision on expert data that the level of antibodies increases when a booster dose is given.
“The risk of inflammatory effects of the heart or other side effects, very rare, after a third dose are not known and are being carefully monitored,” the agency added.
In some rare cases in young people, myocarditis, an inflammation of the heart muscle, occurs after taking the third dose.
The EMA also ruled that people with weakened immune systems could receive an additional dose of Moderna and Pfizer vaccine at least 28 days after their second dose.
Two doses are sometimes not enough to produce enough antibodies in people with impaired immunity.
Although so far the EMA had not given its approval for the boosting dose of the vaccine, some EU countries already offer such an opportunity to their citizens.
To be part of the group »AOL“just click: Join Group and your request will be approved immediately.